Cedara Software is developing a computer-assisted detection system for breast ultrasound. The software, announced as a work-in-progress at the RSNA meeting, is intended to identify the sonographic characteristics of benign as well as malignant breast masses and to classify the extent of malignancy for specific nodules.
Cedara Software is developing a computer-assisted detection system for breast ultrasound. The software, announced as a work-in-progress at the RSNA meeting, is intended to identify the sonographic characteristics of benign as well as malignant breast masses and to classify the extent of malignancy for specific nodules.
The company is evolving four configurations of the breast CAD system, which require FDA approval before commercialization in the U.S. B-CAD will identify features of user-defined lesions that correspond to the BI-RADS lexicon in ultrasound images. B-CAD Plus, in addition to flagging user-defined breast lesions, will use sonographic characteristics to compute the probability of malignancy. B-CAD Pro will identify breast lesions and their features. B-CAD Live will provide all the features of the other CAD options in real-time.
The Cedara B-CAD technology was based on the analysis of more than 1400 images and data from patients with healthy breast tissue, as well as cases with known clinical outcomes following the diagnosis of a breast malignancy.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.